journal article·2010-12

Tailored sizes of constrictive external vein meshes for coronary artery bypass surgery

Thomas Franz, Paul Human, Stephan Dobner, B. Daya Reddy, Melanie Black, Helen Ilsley, Michael F. Wolf, Deon Bezuidenhout, Lovendran Moodley, Peter Zilla

Biomaterials· Volume 31· Issue 35
Publisher page

Abstract

External mesh constriction of vein grafts was shown to mitigate intimal hyperplasia by lowering circumferential wall stress and increasing fluid shear stress. As under-constriction leaves vein segments unsupported and thus prone to neointimal proliferation while over-constriction may cause wall folding optimal mesh sizing holds a key to clinical success. Diameter fluctuations and the occurrence of wall folding as a consequence of external constriction with knitted Nitinol meshes were assessed in saphenous vein grafts from 100 consecutive coronary artery bypass (CABG) patients. Subsequently, mesh dimensions were identified that resulted in the lowest number of mesh sizes for all patients either guaranteeing tight continual mesh contact along the entire graft length (stipulation A) or preventing wall folding (stipulation B). A mathematical data classification analysis and a statistical single-stage partitioning approach were independently applied alternatively prioritizing stipulation A or B. Although the risk of folding linearly increased when constriction exceeded 24.6% (Chi squared test p = 0.0004) the actual incidence of folding (8.6% of veins) as well as the degree of lumenal encroachment (6.2 ± 2.1%) were low. Folds were always single, narrow longitudinal formations (height: 23.3 ± 4.0% of inner diameter/base: 16.6 ± 18.1% of luminal circumference). Both analytical methods provided an optimum number of 4 mesh sizes beyond which no further advantage was seen. While the size ranges recommended by both methods assured continual tight mesh contact with the vein the narrower range suggested by the mathematical data classification analysis (3.0-3.7 mm) put 20.6 ± 12.5% of length in 69% of veins at risk of folding as opposed to 21.3 ± 25.9% being at risk in the wider size range (3.0-4.2 mm) suggested by the statistical partitioning approach. Four mesh sizes would provide uninterrupted mesh contact in 98% of vein grafts in CABG procedures with only 26% of their length being at risk of relatively mild wall folding.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac and Coronary Surgery Techniques · Coronary Interventions and Diagnostics · Cardiac Valve Diseases and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (27)

Show source-provided references
1. New stent for support of veins in arterial grafts10.1001/archsurg.1963.01310160158031 ↗
2. Great saphenous vein protection in arterial reconstructive surgery10.1016/S0950-821X(89)80091-X ↗
3. External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting10.1038/nm0298-235 ↗
4. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath10.1016/j.jvs.2004.08.047 ↗
5. Constrictive external nitinol meshes inhibit vein graft intimal hyperplasia in nonhuman primates10.1016/j.jtcvs.2008.02.068 ↗
6. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the extent study10.1016/j.jtcvs.2007.01.092 ↗
7. Utilization of shape memory in external vein-graft meshes allows extreme diameter constriction for suppressing intimal hyperplasia: a non-human primate study10.1016/j.jvs.2009.01.068 ↗
8. Kinetics of vein graft hyperplasia: association with tangential stress10.1016/0741-5214(87)90203-5 ↗
9. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts10.1161/01.RES.69.6.1557 ↗
10. Prevention of focal intimal hyperplasia in rat vein grafts by using a tissue engineering approach10.1016/S0021-9150(98)00143-9 ↗
11. Biogenesis and etiology of distal anastomotic intimal hyperplasia
12. Flow dynamics across end-to-end vascular bypass graft anastomoses10.1007/BF02368624 ↗
13. Serial angiograpic evaluation in 60 consecutive patients with aorto-coronary artery vein grafts 2 weeks, 1 year, and 3 years after operation10.1016/S0022-5223(19)39755-7 ↗
14. Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively10.1016/0002-9149(77)90041-8 ↗
15. Impact of a color-flow duplex surveillance program on infrainguinal vein graft patency: a five-year experience10.1016/0741-5214(93)90008-A ↗
16. Aortocoronary saphenous vein bypass graft changes 5 to 7 years after surgery
17. Durability of femoropopliteal reconstructions. Endarterectomy versus vein bypass grafts10.1016/0002-9610(72)90202-4 ↗
18. Factors influencing patency of the autogenous vein-femoropopliteal bypass graft: an analysis of 74 cases
19. Autogenous veins and velour dacron in femoropopliteal arterial bypass
20. Dimensional analysis of human saphenous vein grafts: implications for external mesh support10.1016/j.jtcvs.2008.10.040 ↗
21. A mathematical method for constraint-based cluster analysis towards optimized constrictive diameter smoothing of saphenous vein grafts10.1007/s11517-010-0600-7 ↗
22. Improved results with femoropopliteal vein grafts for limb salvage10.1001/archsurg.1977.01370050027004 ↗
23. Discussion of long-term results in superficial femoral artery endarterectomy
24. The advantages of the great saphenous vein as a femoropopliteal graft. A report on its clinical use10.3109/14017438009101013 ↗
25. The closure index: prediction of long-term patency of femoropopliteal vein grafts
26. Mesh-constricted varicose and dilated veins used as arterial bypass grafts10.1177/039139889101400710 ↗
27. Mesh tube-constricted varicose veins used as bypass grafts for infrainguinal arterial reconstruction10.1001/archsurg.1992.01420040058010 ↗